Literature DB >> 31724090

Three-dimensional choroidal vascularity index in acute central serous chorioretinopathy using swept-source optical coherence tomography.

Jingyuan Yang1,2, Erqian Wang1,2, Mingzhen Yuan1,2, Youxin Chen3,4.   

Abstract

PURPOSE: To evaluate the three-dimensional choroidal vascularity index (CVI) in the eyes with treatment-naïve acute central serous chorioretinopathy (CSC) using swept-source optical coherence tomography (SS OCT).
METHODS: In this prospective cross-sectional study, OCT and OCT angiography covered an area of 12 × 12 mm centered on the fovea. Three-dimensional CVI was defined as the ratio of the choroidal vascular luminal volume to the total choroidal volume. The location of pigment epithelial detachment (PED) and the area with abnormal perfusion at choriocapillary layer were compared with the distribution of the three-dimensional CVI.
RESULTS: Thirty-two eyes with treatment-naïve acute CSC, 18 fellow eyes, and 48 control eyes were enrolled. Three-dimensional CVI had good repeatability on control eyes, with a coefficient of variation of 0.166. The mean CVI in the scan area was 0.35 in the eyes with CSC, 0.34 in the fellow eyes of CSC, and 0.30 in the control eyes. The overall CVI in the control eyes was significantly lower than that in the eyes with CSC and that in fellow eyes (P < 0.001 and P = 0.006, respectively). The eyes with CSC and the fellow eyes had significantly higher CVI values at the posterior pole and the drainage routes of choroidal veins. In the eyes with CSC, PEDs and choriocapillary with abnormal perfusion colocalized with the dilated choroidal vessels, which had high three-dimensional CVI values.
CONCLUSION: Increased three-dimensional CVI suggested an increased vascular component in the eyes with CSC and in fellow eyes. The three-dimensional CVI is a useful imaging marker of choroidal diseases that volumetrically assesses the choroidal vasculature and might advance our understanding of CSC pathophysiology.

Entities:  

Keywords:  Central serous chorioretinopathy; Choroid; Choroidal vascularity index; Optical coherence tomography

Year:  2019        PMID: 31724090     DOI: 10.1007/s00417-019-04524-7

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  24 in total

1.  Optical coherence tomography-assisted enhanced depth imaging of central serous chorioretinopathy.

Authors:  Lihong Yang; Jost B Jonas; Wenbin Wei
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-12       Impact factor: 4.799

Review 2.  Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis.

Authors:  Alejandra Daruich; Alexandre Matet; Ali Dirani; Elodie Bousquet; Min Zhao; Nicolette Farman; Frédéric Jaisser; Francine Behar-Cohen
Journal:  Prog Retin Eye Res       Date:  2015-05-27       Impact factor: 21.198

3.  Attenuation correction assisted automatic segmentation for assessing choroidal thickness and vasculature with swept-source OCT.

Authors:  Hao Zhou; Zhongdi Chu; Qinqin Zhang; Yining Dai; Giovanni Gregori; Philip J Rosenfeld; Ruikang K Wang
Journal:  Biomed Opt Express       Date:  2018-11-08       Impact factor: 3.732

4.  Infrared absorption angiography of the fundus circulation.

Authors:  K Kogure; N J David; U Yamanouchi; E Choromokos
Journal:  Arch Ophthalmol       Date:  1970-02

5.  Characteristics of the Choriocapillaris Layer in Optical Coherence Tomography Angiography of Acute Central Serous Chorioretinopathy.

Authors:  Yi Qu; Di Gong; Weihong Yu; Fangtian Dong
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2017-12-01       Impact factor: 1.300

6.  Choroidal Vascular Flow Area in Central Serous Chorioretinopathy Using Swept-Source Optical Coherence Tomography Angiography.

Authors:  Massimo Nicolò; Raffaella Rosa; Donatella Musetti; Maria Musolino; Michela Saccheggiani; Carlo Enrico Traverso
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-04-01       Impact factor: 4.799

Review 7.  Central serous chorioretinopathy.

Authors:  Raffael Liegl; Michael W Ulbig
Journal:  Ophthalmologica       Date:  2014-04-26       Impact factor: 3.250

8.  Classification of image artefacts in optical coherence tomography angiography of the choroid in macular diseases.

Authors:  Fred K Chen; Rian D Viljoen; Danuta M Bukowska
Journal:  Clin Exp Ophthalmol       Date:  2016-02-11       Impact factor: 4.207

9.  Visualizing the Choriocapillaris Under Drusen: Comparing 1050-nm Swept-Source Versus 840-nm Spectral-Domain Optical Coherence Tomography Angiography.

Authors:  Mark Lane; Eric M Moult; Eduardo A Novais; Ricardo N Louzada; Emily D Cole; ByungKun Lee; Lennart Husvogt; Pearse A Keane; Alastair K Denniston; André J Witkin; Caroline R Baumal; James G Fujimoto; Jay S Duker; Nadia K Waheed
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799

10.  Retinal and choroidal changes in steroid-associated central serous chorioretinopathy.

Authors:  Vikas Ambiya; Abhilash Goud; Mohammed Abdul Rasheed; Sankeert Gangakhedkar; Kiran Kumar Vupparaboina; Jay Chhablani
Journal:  Int J Retina Vitreous       Date:  2018-04-02
View more
  17 in total

1.  Choroidal vascularity index in pseudoexfoliative glaucoma.

Authors:  Melisa Zisan Karslioglu; Cem Kesim; Ozum Yucel; Ayse Yildiz Tas; Safak Torun; Cigdem Altan; Afsun Sahin
Journal:  Int Ophthalmol       Date:  2021-08-05       Impact factor: 2.031

Review 2.  Choroidal imaging using optical coherence tomography: techniques and interpretations.

Authors:  Tetsuju Sekiryu
Journal:  Jpn J Ophthalmol       Date:  2022-02-16       Impact factor: 2.447

Review 3.  Pachychoroid disease spectrum: review article.

Authors:  Thiago José Muniz Machado Mazzeo; Henrique Monteiro Leber; Allan Gomes da Silva; Raimunda Cristina Mendonça Freire; Gabriel Castilho Sandoval Barbosa; Guilherme Garcia Criado; Gabriel Almeida Veiga Jacob; Cleide Guimarães Machado; André Marcelo Vieira Gomes
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-10-14       Impact factor: 3.117

4.  Association between central serous chorioretinopathy susceptibility genes and choroidal parameters.

Authors:  Kazuya Morino; Masahiro Miyake; Takuro Kamei; Takahisa Kawaguchi; Yuki Mori; Yoshikatsu Hosoda; Akihito Uji; Kenji Yamashiro; Fumihiko Matsuda; Akitaka Tsujikawa
Journal:  Jpn J Ophthalmol       Date:  2022-10-01       Impact factor: 2.211

5.  Various configuration types of the foveal avascular zone with related factors in normal Chinese adults with or without myopia assessed by swept-source OCT angiography.

Authors:  Yan-Min Dong; Hai-Yan Zhu; Zhen-Hui Liu; Shu-Ying Fu; Ke Wang; Li-Ping Du; Xue-Min Jin
Journal:  Int J Ophthalmol       Date:  2022-09-18       Impact factor: 1.645

Review 6.  [Central serous chorioretinopathy].

Authors:  Laurenz Pauleikhoff; Hansjürgen Agostini; Clemens Lange
Journal:  Ophthalmologe       Date:  2021-04-16       Impact factor: 1.059

7.  Application of Improved U-Net Convolutional Neural Network for Automatic Quantification of the Foveal Avascular Zone in Diabetic Macular Ischemia.

Authors:  Yongan Meng; Hailei Lan; Yuqian Hu; Zailiang Chen; Pingbo Ouyang; Jing Luo
Journal:  J Diabetes Res       Date:  2022-02-26       Impact factor: 4.011

8.  Retinal and Choroidal Vascular Perfusion and Thickness Measurement in Diabetic Retinopathy Patients by the Swept-Source Optical Coherence Tomography Angiography.

Authors:  Tingting Liu; Wei Lin; Genggeng Shi; Wenqi Wang; Meng Feng; Xiao Xie; Tong Liu; Qingjun Zhou
Journal:  Front Med (Lausanne)       Date:  2022-03-18

Review 9.  Choroidal Vascularity Index: An In-Depth Analysis of This Novel Optical Coherence Tomography Parameter.

Authors:  Claudio Iovino; Marco Pellegrini; Federico Bernabei; Enrico Borrelli; Riccardo Sacconi; Andrea Govetto; Aldo Vagge; Antonio Di Zazzo; Matteo Forlini; Lucia Finocchio; Adriano Carnevali; Giacinto Triolo; Giuseppe Giannaccare
Journal:  J Clin Med       Date:  2020-02-21       Impact factor: 4.241

10.  Choroidal vascular changes in retinitis pigmentosa patients detected by optical coherence tomography angiography.

Authors:  Chang Shen; Yang Li; Qian Wang; Yu-Ning Chen; Wei Li; Wen-Bin Wei
Journal:  BMC Ophthalmol       Date:  2020-09-29       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.